These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11668664)

  • 1. The prediction of nonresponse to pharmacotherapy in panic disorder: a review.
    Slaap BR; den Boer JA
    Depress Anxiety; 2001; 14(2):112-22. PubMed ID: 11668664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A naturalistic 6-year follow-up study of patients with panic disorder.
    Lepola U; Koponen H; Leinonen E
    Acta Psychiatr Scand; 1996 Mar; 93(3):181-3. PubMed ID: 8739663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series.
    Otto MW; Pollack MH; Penava SJ; Zucker BG
    Behav Res Ther; 1999 Aug; 37(8):763-70. PubMed ID: 10452176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.
    Roy-Byrne PP; Craske MG; Stein MB; Sullivan G; Bystritsky A; Katon W; Golinelli D; Sherbourne CD
    Arch Gen Psychiatry; 2005 Mar; 62(3):290-8. PubMed ID: 15753242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
    Oei TP; Llamas M; Evans L
    Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute treatment response in outpatients with panic disorder: high versus low depressive symptoms.
    Black DW; Wesner R; Bowers W; Monahan P; Gabel J
    Ann Clin Psychiatry; 1995 Dec; 7(4):181-8. PubMed ID: 8721892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive-behavioral group therapy for panic disorder in the general clinical setting: a naturalistic study with 1-year follow-up.
    Martinsen EW; Olsen T; Tønset E; Nyland KE; Aarre TF
    J Clin Psychiatry; 1998 Aug; 59(8):437-42; quiz 443. PubMed ID: 9721829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do panic symptoms during periods of remission predict relapse of panic disorder?
    Weisberg RB; Machan JT; Dyck IR; Keller MB
    J Nerv Ment Dis; 2002 Mar; 190(3):190-7. PubMed ID: 11923654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term course and outcome in panic disorder: a naturalistic follow-up study.
    Cowley DS; Flick SN; Roy-Byrne PP
    Anxiety; 1996; 2(1):13-21. PubMed ID: 9160594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Galway Study of Panic Disorder. III. Outcome at 5 to 6 years.
    O'Rourke D; Fahy TJ; Brophy J; Prescott P
    Br J Psychiatry; 1996 Apr; 168(4):462-9. PubMed ID: 8730943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C; Schulberg HC; Shear MK
    Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after a drug trial for panic disorder.
    Katschnig H; Amering M; Stolk JM; Klerman GL; Ballenger JC; Briggs A; Buller R; Cassano G; Garvey M; Roth M
    Br J Psychiatry; 1995 Oct; 167(4):487-94. PubMed ID: 8829718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSM-III-R Axis I and II disorders in agoraphobic inpatients with and without panic disorder before and after psychosocial treatment.
    Hoffart A; Thornes K; Hedley LM
    Psychiatry Res; 1995 Jan; 56(1):1-9. PubMed ID: 7792336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The longitudinal course and outcome of panic disorder.
    Pollack MH; Smoller JW
    Psychiatr Clin North Am; 1995 Dec; 18(4):785-801. PubMed ID: 8748381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.
    Albus M; Scheibe G; Scherer J
    J Affect Disord; 1995 May; 34(2):109-15. PubMed ID: 7665802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term drug treatment of panic disorder.
    Burrows GD; Judd FK; Norman TR
    J Psychiatr Res; 1993; 27 Suppl 1():111-25. PubMed ID: 7908330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA; Schweizer E; Rickels K
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder].
    Boerner RJ; Lühring F
    Psychiatr Prax; 2010 Oct; 37(7):350-2. PubMed ID: 20703987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression.
    Frank E; Shear MK; Rucci P; Cyranowski JM; Endicott J; Fagiolini A; Grochocinski VJ; Houck P; Kupfer DJ; Maser JD; Cassano GB
    Am J Psychiatry; 2000 Jul; 157(7):1101-7. PubMed ID: 10873918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.